SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)

SARS-CoV-2 nucleic acid IVD kits use molecular techniques to detect genetic material from the virus responsible for COVID-19 in clinical samples. These tests help confirm active infection by identifying viral RNA, enabling rapid and accurate diagnosis for clinical management and public health monitoring.

These devices are typically regulated as in vitro diagnostics (IVDs) and may require validation for performance, safety, and clinical accuracy. They are supplied as reagent kits, often including extraction buffers, primers, probes, and controls, designed for use in laboratory settings with appropriate instrumentation.